<DOC>
	<DOCNO>NCT03003559</DOCNO>
	<brief_summary>For AECOPD patient , 8 % patient ventilate noninvasive invasive positive pressure ventilation . Nasal cannula common pattern oxygen therapy mild AECOPD . As low flow oxygen therapy , nasal cannula many disadvantages.Therefore , design randomize control trial ( RCT ) explore whether HFNC would better nasal cannula prevent aggravation respiratory failure endotracheal intubation mild AECOPD .</brief_summary>
	<brief_title>HFNC v Nasal Cannula Mild Chronic Obstructive Pulmonary Disease Exacerbation</brief_title>
	<detailed_description>For AECOPD patient , patient n't need respiratory support , 8 % patient ventilate noninvasive invasive positive pressure ventilation . Nasal cannula common pattern oxygen therapy mild AECOPD . As low flow oxygen therapy , nasal cannula many disadvantage : discomfort , low humidity unstable fraction inspire oxygen ( FiO2 ) inspiratory gas . Therefore , design RCT explore whether HFNC would better nasal cannula prevent aggravation respiratory failure endotracheal intubation mild AECOPD .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Disease Progression</mesh_term>
	<criteria>AECOPD ; pHâ‰¥7.35 , PaCO2 &gt; 45 mmHg Need intubate immediately ; refuse engage study ; severe organ dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>COPD Exacerbation</keyword>
	<keyword>High Flow Oxygen</keyword>
	<keyword>Nasal Cannula</keyword>
	<keyword>mild</keyword>
</DOC>